Existing horizon scanning activities could be strengthened to aid budget planning in the context of high upfront cost therapies such as gene therapies. International collaborations could be leveraged ...

The Office of Health Economics is delighted to host the Health Economists’ Study Group Summer Meeting, which will run from 30th June – 2nd July 2025. Founded in 1972, the Health Economists’ Study ...

The policy environment for rare disease and orphan medicines is complex and encompasses regulation, reimbursement, and ...

Last week, researchers from across the UK and Ireland met at Holborn’s Conway Hall for a day of stimulating presentations and ...

Dimitrios is an economist and his research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D. In addition, he is interested ...

Hannah joined OHE as an Economist in September 2024. She holds an MPharm degree from the University of Nottingham and an MSc in Health Economics and Health Policy from the University of Birmingham. As ...

Dr. Inmaculada (Inma) Hernandez is a Professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Hernandez is a pharmacist and a scholar whose ...

Dr Seán Byrne is Senior Manager, Legal & Regulatory Affairs for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Seán represents EUCOPE members at relevant European Medicines ...

Luigi Siciliani is a Professor of Health Economics at the Department of Economics and Related Studies at the University of York, where he directs the MSc in Health Economics. He is currently an Editor ...